FERRARO, Diana
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.210
AS - Asia 5.582
EU - Europa 5.293
SA - Sud America 1.014
Continente sconosciuto - Info sul continente non disponibili 213
AF - Africa 149
OC - Oceania 51
Totale 29.512
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.763
GB - Regno Unito 1.741
SG - Singapore 1.636
CN - Cina 1.276
IT - Italia 950
VN - Vietnam 779
BR - Brasile 751
HK - Hong Kong 732
DE - Germania 484
SE - Svezia 411
FI - Finlandia 389
BD - Bangladesh 308
RU - Federazione Russa 260
FR - Francia 247
CA - Canada 214
UA - Ucraina 201
TR - Turchia 135
BG - Bulgaria 129
IN - India 118
KR - Corea 113
AR - Argentina 95
ID - Indonesia 95
MX - Messico 76
ES - Italia 69
NL - Olanda 57
CZ - Repubblica Ceca 51
PL - Polonia 51
AU - Australia 50
JP - Giappone 50
IQ - Iraq 49
AT - Austria 43
EC - Ecuador 42
ZA - Sudafrica 42
AE - Emirati Arabi Uniti 35
IE - Irlanda 35
CL - Cile 31
MY - Malesia 29
PK - Pakistan 29
CR - Costa Rica 27
IR - Iran 27
CH - Svizzera 26
BE - Belgio 25
CO - Colombia 25
DK - Danimarca 25
VE - Venezuela 24
MA - Marocco 20
PH - Filippine 20
EG - Egitto 19
IL - Israele 18
JO - Giordania 17
LT - Lituania 17
PY - Paraguay 17
KE - Kenya 16
TN - Tunisia 16
TT - Trinidad e Tobago 15
JM - Giamaica 14
SV - El Salvador 14
PR - Porto Rico 13
BZ - Belize 12
GT - Guatemala 12
PE - Perù 12
TW - Taiwan 12
UY - Uruguay 12
SA - Arabia Saudita 11
GE - Georgia 10
HN - Honduras 10
PT - Portogallo 10
UZ - Uzbekistan 10
NP - Nepal 9
AZ - Azerbaigian 8
DO - Repubblica Dominicana 8
RO - Romania 8
EE - Estonia 7
GP - Guadalupe 7
NI - Nicaragua 7
NO - Norvegia 7
BB - Barbados 6
DZ - Algeria 6
GR - Grecia 6
HU - Ungheria 6
OM - Oman 6
QA - Qatar 6
TH - Thailandia 6
AL - Albania 5
KZ - Kazakistan 5
LB - Libano 5
RS - Serbia 5
SC - Seychelles 5
SI - Slovenia 5
BO - Bolivia 4
PA - Panama 4
PS - Palestinian Territory 4
SK - Slovacchia (Repubblica Slovacca) 4
SN - Senegal 4
BA - Bosnia-Erzegovina 3
BS - Bahamas 3
ET - Etiopia 3
GA - Gabon 3
HR - Croazia 3
KW - Kuwait 3
Totale 29.243
Salva come PNG Salva come JPEG
Città #
Ashburn 1.822
Fairfield 1.819
Santa Clara 1.415
Southend 1.203
Singapore 961
Woodbridge 872
Seattle 722
Hong Kong 720
Houston 713
San Jose 641
Chandler 625
Cambridge 605
Wilmington 554
Council Bluffs 504
Ann Arbor 354
Helsinki 326
Chicago 323
Dearborn 317
London 301
Jacksonville 292
Nyköping 284
Ho Chi Minh City 255
Los Angeles 252
New York 239
Beijing 227
Hanoi 183
Modena 177
Hefei 165
The Dalles 156
San Diego 143
Munich 135
Princeton 122
Sofia 122
Salt Lake City 111
Dallas 91
Carrboro 89
Milan 88
Shanghai 88
Buffalo 87
Moscow 86
Seoul 81
Lauterbourg 78
Columbus 73
Eugene 73
São Paulo 70
Jakarta 66
Toronto 62
North Bergen 61
Frankfurt am Main 55
Tampa 53
Phoenix 51
Rome 51
Elk Grove Village 50
Bremen 47
Orem 45
Izmir 44
Redwood City 42
Miami 41
Norwalk 39
Da Nang 38
Saint Augustine 37
Warsaw 35
Boardman 34
Rio de Janeiro 32
Tokyo 31
Washington 31
Boston 30
Manchester 30
Málaga 30
Redondo Beach 30
Brno 29
Guangzhou 29
Montreal 29
Dublin 28
Sterling 28
Turku 28
Vienna 27
Fremont 26
Haiphong 26
Lancaster 26
Amsterdam 25
Atlanta 25
Brooklyn 25
Melbourne 24
Naples 24
Chennai 23
Seongnam 23
Stockholm 23
Dulles 22
Hillsboro 22
Johannesburg 22
Kunming 22
San Francisco 22
Baghdad 21
Paris 21
Mexico City 20
Miano 20
Newark 20
Nuremberg 20
San José 20
Totale 20.349
Salva come PNG Salva come JPEG
Nome #
Definitive childlessness in women with multiple sclerosis: a multicenter study 701
Cerebrospinal fluid CXCL13 in clinically isolated syndrome patients: Association with oligoclonal IgM bands and prediction of Multiple Sclerosis diagnosis 494
Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study 475
Cerebrospinal fluid oligoclonal IgM bands predict early conversion to clinically definite multiple sclerosis in patients with Clinically Isolated Syndrome. 471
A quantitative comparison of BOLD fMRI responses to noxious and innocuous stimuli in the human spinal cord 427
Invariant natural killer T cells and mucosal-associated invariant T cells in multiple sclerosis 424
Aging with HIV infection: a journey to the center of inflammAIDS, immunosenescence and neuroHIV 419
Isolated progressive cognitive impairment and depression in a patient with neuroradiological features suggestive of multiple sclerosis 409
Percutaneous endoscopic gastrostomy, body weight loss and survival in amyotrophic lateral sclerosis: a population-based registry study 405
Recurrent varicella following steroids and fingolimod in a Multiple Sclerosis patient 403
Previous treatment influences fingolimod efficacy in relapsing-remitting multiple sclerosis: Results from an observational study 392
iNKT cells in secondary progressive multiple sclerosis patients display pro-inflammatory profiles 391
A multicenter study on the diagnostic significance of a single cerebrospinal fluid IgG band 390
First-line disease-modifying drugs in relapsing-remitting multiple sclerosis: an Italian real-life multicenter study on persistence 385
False positive absent somatosensory evoked potentials in cardiac arrest with therapeutic hypothermia. 380
Changing incidence and subtypes of ALS in Modena, Italy: A 10-years prospective study 369
Amyotrophic lateral sclerosis: a comparison of two staging systems in a population-based study 358
Acute hemichorea as unusual first multiple sclerosis presentation 355
Mitochondrial functionality and metabolism in T cells from progressive multiple sclerosis patients 354
Mitochondrial damage-associated molecular patterns stimulate reactive oxygen species production in human microglia 352
Cerebrospinal fluid anti-Epstein-Barr virus specific oligoclonal IgM and IgG bands in patients with clinically isolated and Guillain-Barré syndrome 351
"Better explanations" in multiple sclerosis diagnostic workup: A 3-year longitudinal study 349
Paroxysmal ventricular tachicardia and pure right insular stroke 349
Increased plasma levels of mitochondrial DNA and pro-inflammatory cytokines in patients with progressive multiple sclerosis 336
Platelet Function Testing in Patients with Acute Ischemic Stroke: An Observational Study 330
Methylprednisolone-induced toxic hepatitis after intravenous pulsed therapy for multiple sclerosis relapses 328
Anti-inflammatory disease-modifying treatment and disability progression in primary progressive multiple sclerosis: a cohort study 325
Cerebrospinal fluid kappa and lambda free light chains in oligoclonal band‐negative patients with suspected multiple sclerosis 324
Inter-center agreement in the interpretation of oligoclonal bands 310
Primary progressive versus relapsing-onset multiple sclerosis: presence and prognostic value of cerebrospinal fluid oligoclonal IgM 308
Plasma neurofilaments correlate with disability in progressive multiple sclerosis patients 306
Acute coronary syndrome associated with alemtuzumab infusion in multiple sclerosis 301
Semiautomated segmentation of the human spine based on echoplanar images 296
Antiepileptic drugs in the treatment of headache: Neuroprotective effect or something else? 293
TIMP-1 resistant matrix metalloproteinase-9 is the predominant serum active isoform associated with MRI activity in patients with multiple sclerosis 293
Severe anemia in a patient with multiple sclerosis treated with natalizumab 290
Cerebrospinal fluid amounts of HLA-G in dimeric form are strongly associated to patients with MRI inactive multiple sclerosis 284
Anti-inflammatory disease-modifying treatment and short-term disability progression in SPMS 283
Topiramate and triptans revert chronic migraine with medication overuse to episodic migraine 280
Diagnostics of dysimmune peripheral neuropathies 280
Systematic assessment and characterization of chronic pain in multiple sclerosis patients 279
Acute necrotizing encephalopathy: A relapsing case in a European adult [4] 278
Frequent early multiple sclerosis relapses during treatment with fingolimod: a paradoxical effect? 276
Diagnostics of anti-MAG antibody polyneuropathy 273
Abnormal Circadian Modification of Aδ-Fiber Pathway Excitability in Idiopathic Restless Legs Syndrome 271
Antibiotic Use and Risk of Multiple Sclerosis: A Nested Case-Control Study in Emilia-Romagna Region, Italy 270
Topiramate in migraine prophylaxis: A randomised double-blind versus placebo study 267
Disability outcomes of early cerebellar and brainstem symptoms in multiple sclerosis 265
Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis 264
Intrathecal oligoclonal bands synthesis in multiple sclerosis: is it always a prognostic factor? 263
Antiepileptic drugs in the preventive treatment of migraine in children and adolescents 260
Charcot-Marie-Tooth and pain: Correlations with neurophysiological, clinical, and disability findings 256
The abnormal recovery cycle of somatosensory evoked potential components in children with migraine can be reversed by topiramate 256
Habituation to Pain in "Medication Overuse Headache": A CO2 Laser-Evoked Potential Study 252
Serum IgG against Simian Virus 40 antigens are hampered by high levels of sHLA-G in patients affected by inflammatory neurological diseases, as multiple sclerosis 251
Treatment of relapsing-remitting multiple sclerosis after 24 doses of natalizumab: evidence from an Italian spontaneous, prospective, and observational study (the TY-STOP Study) 250
Mechanisms of neuropathic pain in patients with Charcot-Marie-Tooth 1 A: A laser-evoked potential study 248
Comparison of fingolimod, dimethyl fumarate and teriflunomide for multiple sclerosis 248
Detection of Neurofilament Light Chain with Label-Free Electrolyte-Gated Organic Field-Effect Transistors 248
The real-world effectiveness of natalizumab and fingolimod in relapsing-remitting multiple sclerosis. An Italian multicentre study 247
Acute hemichorea as unusual first multiple sclerosis presentation: two case reports 238
Characteristics and treatment of Multiple Sclerosis-related trigeminal neuralgia: An Italian multi-centre study 236
Immunosenescence and vaccine efficacy revealed by immunometabolic analysis of SARS-CoV-2-specific cells in multiple sclerosis patients 234
Left thalamomegaly in a patient with partial epilepsy 233
Topiramate in the prevention of pediatric migraine: Literature review 232
Biological markers in cerebrospinal fluid for axonal impairment in multiple sclerosis: Acetylcholinesterase activity cannot be considered a useful biomarker 231
Incidence of pregnancy and disease-modifying therapy exposure trends in women with multiple sclerosis: A contemporary cohort study 230
Multiple attack study on the available triptans in Italy versus placebo 228
Letter to Editor: Carpal tunnel syndrome due to an atypical deep soft tissue leiomyoma: The risk of misdiagnosis and mismanagement 225
Predictors of relapse and disability progression in MS patients who discontinue disease-modifying therapy 222
Cell-based assays for the detection of MOG antibodies: a comparative study 221
Association of Inflammation and Disability Accrual in Patients With Progressive-Onset Multiple Sclerosis 218
A voxel-based lesion symptom mapping analysis of chronic pain in multiple sclerosis 218
Evidence of different spinal pathways for the warmth evoked potentials 217
Kappa Index Versus CSF Oligoclonal Bands in Predicting Multiple Sclerosis and Infectious/Inflammatory CNS Disorders 215
A multicenter survey on access to care in Multiple Sclerosis-related trigeminal neuralgia 213
Informing MS patients on treatment options: a consensus on the process of consent taking 210
Treatment response score to glatiramer acetate or interferon beta-1a 210
Antiepileptic drugs in migraine prophylaxis: state of the art 207
Dimethyl fumarate-induced lymphocyte count drop is related to clinical effectiveness in relapsing–remitting multiple sclerosis 207
Diagnostic features of initial demyelinating events associated with serum MOG-IgG 206
Microglia activation: A role for mitochondrial DNA? 205
Occupational head injury and subsequent glioma 200
Risk of secondary progressive multiple sclerosis: A longitudinal study 197
Cladribine versus fingolimod, natalizumab and interferon β for multiple sclerosis 196
Modulation of tregs and inkt by fingolimod in multiple sclerosis patients 196
Effect of Disease-Modifying Therapy on Disability in Relapsing-Remitting Multiple Sclerosis Over 15 Years 189
Simultaneous quantification of natural and inducible regulatory T-cell subsets during interferon-β therapy of multiple sclerosis patients 186
Serum neurofilament light as biomarker of seizure-related neuronal injury in status epilepticus 186
Conversion to secondary progressive multiple sclerosis: Patient awareness and needs. Results from an online survey in Italy and Germany 183
A novel SOD1 mutation in a young ALS patient associated with slowly progressive clinical course 176
Association of Sustained Immunotherapy with Disability Outcomes in Patients with Active Secondary Progressive Multiple Sclerosis 172
Defining the course of tumefactive multiple sclerosis: A large retrospective multicentre study 167
Clinical and therapeutic predictors of disease outcomes in AQP4-IgG+ neuromyelitis optica spectrum disorder 163
Exit Strategies in Natalizumab-Treated RRMS at High Risk of Progressive Multifocal Leukoencephalopathy: a Multicentre Comparison Study 154
A study of the CD45 exon 4 C77G polymorphism in a patient affected both by multiple sclerosis and pulmonary Langerhans' cell histiocytosis 153
Efficacy of mechanical thrombectomy in patients with ischemic stroke and cancer 153
Harmonization of real-world studies in multiple sclerosis: Retrospective analysis from the rirems group 150
The effectiveness of natalizumab vs fingolimod–A comparison of international registry studies 150
Exploring the Role of Diabetes in ALS: A Population-Based Cohort Study 146
Totale 27.765
Salva come PNG Salva come JPEG
Categoria #
all - tutte 120.415
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 120.415
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.538 0 0 0 0 40 134 107 141 252 225 403 236
2022/20231.749 198 206 146 181 198 250 21 191 193 13 102 50
2023/20241.247 33 77 60 158 229 108 147 155 30 15 63 172
2024/20254.290 151 37 47 322 911 713 198 213 499 242 382 575
2025/20268.873 525 336 704 1.013 1.399 673 967 476 842 727 681 530
2026/20272.679 383 526 618 1.149 3 0 0 0 0 0 0 0
Totale 29.512